| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |